El Vínculo El Vínculo.
Awarded European Union Services

IIT study CLEAR "Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)"

Buyer: Universitätsklinikum Münster

Published
9 April 2025
Place of performance
Münster, DEA33
Procedure
Open procedure
Lots
1
Notice number
00231115-2025
Reference
39ab6b8e-72b1-4b74-a130-c35aecca2c19
Official source
Official source

CPV codes

Description

The IIT (Investigator Initiated Trial) study CLEAR "Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)" should take place in 26 trial sites in Germany and 4 trial sites in Italy. The University of Münster acts as sponsor of the clinical trial CLEAR according to Article 2 No. 14 Regulation (EU) 536/2014 (CTR). For the conduct of the study in Italy, we would like to transfer the following tasks in the areas of project management, trial start-up, monitoring and quality assurance to another institution in Italy. A synopsis of the study is attached to this tender as Appendix 1. A framework agreement will be concluded afterwards.

Award criteria

Awards

Awarded toAmountDate
Ecol Studio SpA €1

Official publications

Other tenders from Universitätsklinikum Münster

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is Universitätsklinikum Münster (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.